Author

R. Gunsay

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

A. C. Aksu· 1 shared A. D. Cavga· 1 shared A. Kayabolen· 1 shared B. Gokbayrak· 1 shared E. Y. Kala· 1 shared F. Uyulur· 1 shared G. Karabiyik· 1 shared N. A. Lack· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. C. Aksu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivMay 14, 2021

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities

O. Yedier-Bayram, B. Gokbayrak, A. C. Aksu…·T. Bagci-Onder

The paper introduces EPIKOL, a CRISPR-Cas9 library targeting epigenetic modifiers, and demonstrates its utility in identifying cancer-specific epigenetic vulnerabilities in breast and prostate cancer.

DOI 10.1038/s41419-022-05146-4

humangenetic perturbation / CRISPR

𝕏 PostBluesky